Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
CERILLIANT™ Nordiazepam-d5 Solution, 100 μg/mL in Methanol, Sold by MilliporeSigma™ Supelco™
Certified reference material
Supplier: MilliporeSigma Supelco N9031ML
Description
Nordiazepam is a benzodiazepine prescribed for treatment of anxiety and panic attacks. This stable-labeled internal standard is suited for quantitation of nordiazepam levels in urine, serum, or plasma by LC/MS or GC/MS for urine drug testing, clinical toxicology, forensic analysis or isotope dilution methods. Nordiazepam is also a primary urinary metabolite of benzodiazepines diazepam and chlrodiazepoxide.
Specifications
67-56-1, 65891-80-7 | |
UN 1230 - class 3 - PG 2 - Methanol, solution | |
275.74 | |
1 mL |
C15D5H6ClN2O | |
100 μg/mL in methanol | |
Ampule | |
9.7°C (49.5°F) - closed cup |
Safety and Handling
H331-H370
H311
EINECSNumber : 200-659-6
Recommended Storage : -20°C
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
CERILLIANT is a registered trademark of Cerilliant Corporation
Spot an opportunity for improvement?Share a Content Correction